Nutr Clin Pract. 2016 Apr;31(2):180-5.
Recommendations for Manganese Supplementation to Adult Patients Receiving Long-Term Home Parenteral Nutrition: An Analysis of the Supporting Evidence.
Baker B, Ali A, Isenring L.
School of Human Movement Studies, University of Queensland, Brisbane, Queensland, Australia.
Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Faculty of Health Sciences & Medicine, Bond University, Gold Coast, Queensland, Australia.
INTRODUCTION: Manganese (Mn) toxicity is often observed in adult patients receiving long-term home parenteral nutrition (HPN), and differing recommendations on the safe level of Mn administration to these patients have been made in the literature over the past 10 years.
METHODS: This systematic review used the National Health and Medical Research Council (NHMRC) evidence hierarchy to assess the design and strength of individual studies (high I to low IV) and the overall grade of evidence (grade A high to grade D low).
RESULTS: Eight studies met the inclusion criteria. Levels of evidence ranged from high (NHMRC II) to mid-level (III-3). A widespread recommendation in the literature for patients receiving long-term HPN is 55 μg (1 μmol) Mn/d.
CONCLUSION: The recommendation of 55 μg (1μmol) Mn/d is of moderate-strength evidence (NHMRC B grade). There is limited evidence to support not supplementing Mn to patients receiving long-term HPN. Further intervention studies providing high-level evidence (II and above) are required to determine the safety of not supplementing Mn to all patients receiving long-term HPN.
PMID: 26203074
DOI: 10.1177/0884533615591600
联系客服
